Evidence map›Paper›PMID 29804063›Full record

ArticleBMJ open2018

Cancer recording in patients with and without type 2 diabetes in the Clinical Practice Research Datalink primary care data and linked hospital admission data: a cohort study.

Rachael Williams, Tjeerd-Pieter van Staa, Arlene M Gallagher, Tarek Hammad, Hubert G M Leufkens, Frank de Vries

Abstract read
In one paragraph

Article in BMJ open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Prostate-specific antigen testing and opportunistic prostate cancer screening: a cohort study in England, 1998-2017.The British journal of general practice : the journal of the Royal College of General Practitioners · 2021
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rachael WilliamsCPRD, Medicines and Healthcare Products Regulatory Agency, London, UK.
Tjeerd-Pieter van StaaUtrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Arlene M GallagherCPRD, Medicines and Healthcare Products Regulatory Agency, London, UK.
Tarek HammadOffice of Surveillance and Epidemiology, Food and Drug Administration, Silver Spring, Maryland, USA.
Hubert G M LeufkensUtrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Frank de VriesUtrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.

Funding

Wellcome Trust
6 · The paper itself

Abstract

OBJECTIVES AND

settingConflicting results from studies using electronic health records to evaluate the associations between type 2 diabetes and cancer fuel concerns regarding potential biases. This study aimed to describe completeness of cancer recording in UK primary care data linked to hospital admissions records.

designPatients aged 40+ years with insulin or oral antidiabetic prescriptions in Clinical Practice Research Datalink (CPRD) primary care without type 1 diabetes were matched by age, sex and general practitioner practice to non-diabetics. Those eligible for linkage to Hospital Episode Statistics Admitted Patient Care (HES APC), and with follow-up during April 1997-December 2006 were included. PRIMARY AND SECONDARY OUTCOME MEASURES: Cancer recording and date of first record of cancer were compared. Characteristics of patients with cancer most likely to have the diagnosis recorded only in a single data source were assessed. Relative rates of cancer estimated from the two datasets were compared.

participants53 585 patients with type 2 diabetes matched to 47 435 patients without diabetes were included.

resultsOf all cancers (excluding non-melanoma skin cancer) recorded in CPRD, 83% were recorded in HES APC. 94% of cases in HES APC were recorded in CPRD. Concordance was lower when restricted to same-site cancer records, and was negatively associated with increasing age. Relative rates for cancer were similar in both datasets.

conclusionsGood concordance in cancer recording was found between CPRD and HES APC among type 2 diabetics and matched controls. Linked data may reduce misclassification and increase case ascertainment when analysis focuses on site-specific cancers.

Indexed as

AdultAgedAged, 80 and overAge DistributionCohort StudiesDatabases, FactualDiabetes Mellitus, Type 2FemaleHumansLogistic ModelsMaleMedical Record LinkageMiddle AgedMultivariate AnalysisNeoplasmsPatient Admissioncancerconcordanceelectronic health recordshospital admissionsprimary caretype 2 diabetes

Identifiers

PMID29804063
PMCPMC5988054

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.